Analyst Ratings for ANI Pharmaceuticals (ANIP)
ANIP Rating Summary
ANIP Price Target Summary
- Highest: $120.00 (Jefferies)
- Lowest: $90.00 (Canaccord)
- Average: $105.43
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$105.43 (+49.7%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
Avg. $ Target:
$105.43 (+49.7%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/9/2026 | Leerink | Daniel Clark | New Coverage | Outperform (N/A) |
104.00 (N/A) |
70.23 (70.45) |
0.31% | Details |
| 7/16/2026 | Canaccord » Updated 8/10/2026 |
Gary Newman | New Coverage | Hold (N/A) |
90.00 (91.00) |
80.82 (70.45) |
-12.83% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
